Reply to: Prediction of treatment response in patients with locally advanced cervical cancer using midtreatment PET/MRI during concurrent chemoradiotherapy. In regard to Vojtíšek et al
Jazyk angličtina Země Německo Médium print-electronic
Typ dokumentu dopisy, komentáře
PubMed
34292349
DOI
10.1007/s00066-021-01818-w
PII: 10.1007/s00066-021-01818-w
Knihovny.cz E-zdroje
- MeSH
- chemoradioterapie MeSH
- lidé MeSH
- magnetická rezonanční tomografie MeSH
- nádory děložního čípku * diagnostické zobrazování terapie MeSH
- pozitronová emisní tomografie MeSH
- Check Tag
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- dopisy MeSH
- komentáře MeSH
Zobrazit více v PubMed
Vojtíšek R, Baxa J, Kovářová P et al (2021) Prediction of treatment response in patients with locally advanced cervical cancer using midtreatment PET/MRI during concurrent chemoradiotherapy. Strahlenther Onkol 197(6):494–504 DOI
Bhatla N, Berek JS, Cuello Fredes M et al (2019) Revised FIGO staging for carcinoma of the cervix uteri. Int J Gynaecol Obstet 145(1):129–135 DOI
Olawaiye AB, Baker TP, Washington MK, Mutch DG (2021) The new (Version 9) American Joint Committee on Cancer tumor, node, metastasis staging for cervical cancer. CA Cancer J Clin 71(4):287–298 DOI
Amin MB, Edge SB, Greene FL (2017) AJCC cancer staging manual, 8th edn. Springer, New York DOI
Onal C, Reyhan M, Guler OC, Yapar AF (2014) Treatment outcomes of patients with cervical cancer with complete metabolic responses after definitive chemoradiotherapy. Eur J Nucl Med Mol Imaging 41(7):1336–1342 DOI
Grueneisen J, Schaarschmidt BM, Heubner M et al (2015) Integrated PET/MRI for whole-body staging of patients with primary cervical cancer: preliminary results. Eur J Nucl Med Mol Imaging 42(12):1814–1824 DOI